Garnette D. Draper

Array ( [id] => 3963803 [patent_doc_number] => 05885800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'DNA encoding tumor necrosis related receptor, TR4' [patent_app_type] => 1 [patent_app_number] => 8/794796 [patent_app_country] => US [patent_app_date] => 1997-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8213 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885800.pdf [firstpage_image] =>[orig_patent_app_number] => 794796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256730 [patent_doc_number] => 06204021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'DNA encoding a cytokine' [patent_app_type] => 1 [patent_app_number] => 8/792013 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18268 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204021.pdf [firstpage_image] =>[orig_patent_app_number] => 792013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4056143 [patent_doc_number] => 05863769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'DNA encoding interleukin-1 receptor antagonist (IL-1ra.beta.)' [patent_app_type] => 1 [patent_app_number] => 8/790032 [patent_app_country] => US [patent_app_date] => 1997-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8023 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863769.pdf [firstpage_image] =>[orig_patent_app_number] => 790032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981940 [patent_doc_number] => 05861279 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists' [patent_app_type] => 1 [patent_app_number] => 8/785531 [patent_app_country] => US [patent_app_date] => 1997-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7472 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861279.pdf [firstpage_image] =>[orig_patent_app_number] => 785531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007077 [patent_doc_number] => 05962268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'DNA encoding an immune cell cytokine' [patent_app_type] => 1 [patent_app_number] => 8/780370 [patent_app_country] => US [patent_app_date] => 1997-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 2 [patent_no_of_words] => 13166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962268.pdf [firstpage_image] =>[orig_patent_app_number] => 780370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4063290 [patent_doc_number] => 05895647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Use of oral interleukin-6 as therapy for hemorrhagic shock' [patent_app_type] => 1 [patent_app_number] => 8/772225 [patent_app_country] => US [patent_app_date] => 1996-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6374 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895647.pdf [firstpage_image] =>[orig_patent_app_number] => 772225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194257 [patent_doc_number] => 06130318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4' [patent_app_type] => 1 [patent_app_number] => 8/765012 [patent_app_country] => US [patent_app_date] => 1996-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10855 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130318.pdf [firstpage_image] =>[orig_patent_app_number] => 765012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028160 [patent_doc_number] => 05994104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Interleukin-12 fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/751767 [patent_app_country] => US [patent_app_date] => 1996-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 13 [patent_no_of_words] => 30012 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994104.pdf [firstpage_image] =>[orig_patent_app_number] => 751767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799644 [patent_doc_number] => 05830454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Method for treating cell mediated autoimmune disorders using interleukin-9' [patent_app_type] => 1 [patent_app_number] => 8/706302 [patent_app_country] => US [patent_app_date] => 1996-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2303 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830454.pdf [firstpage_image] =>[orig_patent_app_number] => 706302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4102887 [patent_doc_number] => 06022536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Combined use of interleukin 10 and cyclosporin for immunosuppression therapy' [patent_app_type] => 1 [patent_app_number] => 8/694973 [patent_app_country] => US [patent_app_date] => 1996-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6807 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022536.pdf [firstpage_image] =>[orig_patent_app_number] => 694973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784692 [patent_doc_number] => 05840530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'DNA encoding receptors for the beta-2 chain of human IL-12' [patent_app_type] => 1 [patent_app_number] => 8/685118 [patent_app_country] => US [patent_app_date] => 1996-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11007 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840530.pdf [firstpage_image] =>[orig_patent_app_number] => 685118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232811 [patent_doc_number] => 06074849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Polynucleotides encoding human CTLA-8 related proteins' [patent_app_type] => 1 [patent_app_number] => 8/685239 [patent_app_country] => US [patent_app_date] => 1996-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 14902 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074849.pdf [firstpage_image] =>[orig_patent_app_number] => 685239 [rel_patent_id] =>[rel_patent_doc_number] =>)